Global Anti-allergic Drugs Market Growth (Status and Outlook) 2025-2031

The global Anti-allergic Drugs market size is predicted to grow from US$ 46720 million in 2025 to US$ 70250 million in 2031; it is expected to grow at a CAGR of 7.0% from 2025 to 2031.

Anti-allergic drugs are medications used to treat and prevent allergic reactions by targeting the immune system's response to allergens. These drugs help alleviate symptoms associated with allergies, such as sneezing, itching, runny nose, rashes, or swelling, and are commonly used for conditions like hay fever, allergic rhinitis, and skin allergies. Common types of anti-allergic drugs include antihistamines, corticosteroids, decongestants, and leukotriene inhibitors. These medications work by blocking histamines or other inflammatory substances that the body releases during an allergic reaction, reducing the severity of symptoms and providing relief to individuals suffering from allergies.

Global Anti-allergic Drugs includes Sanofi, Johnson And Johnson, etc. Global top two companies hold a share over 10%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific with the share about 30 and 20.

LPI (LP Information)' newest research report, the “Anti-allergic Drugs Industry Forecast” looks at past sales and reviews total world Anti-allergic Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-allergic Drugs sales for 2025 through 2031. With Anti-allergic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-allergic Drugs industry.

This Insight Report provides a comprehensive analysis of the global Anti-allergic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-allergic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-allergic Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-allergic Drugs and breaks down the forecast by Type, by Sales Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-allergic Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-allergic Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:
Oral Drugs
Non-Oral Drugs
Inhalation and Nasal Sprays

Segmentation by Sales Channel:
Online
Offline

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Johnson And Johnson
Merck
Teva
GlaxoSmithKline
Bayer
Sun Pharma
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays
AstraZeneca
Roche
Novartis

Please note: The report will take approximately 2 business days to prepare and deliver.